|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.6 TWD | +1.09% |
|
+3.73% | -7.95% |
| Apr. 08 | Energenesis Biomedical CO.,LTD. announced a financing transaction | CI |
| Feb. 29 | Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Energenesis Biomedical CO.,LTD. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 7.35 million compared to TWD 7.49 million a year ago. Net loss was TWD 265.66 million compared to TWD 120.24 million a year ago.
Basic loss per share from continuing operations was TWD 3.99 compared to TWD 2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.95% | 128M | |
| +0.33% | 42.86B | |
| +12.08% | 42.74B | |
| +44.30% | 41.36B | |
| -6.20% | 27.68B | |
| +5.32% | 25.15B | |
| -24.01% | 18.63B | |
| +27.52% | 12.37B | |
| -3.80% | 11.92B | |
| +7.14% | 11.21B |
ENERGENESIS BIOMEDICAL CO.,LTD. 
